<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-00624</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0000252</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Cell Signaling and Trafficking Structures</subject><subject>Cell Biology/Cell Signaling</subject><subject>Cell Biology/Developmental Molecular Mechanisms</subject><subject>Cell Biology/Neuronal and Glial Cell Biology</subject><subject>Cell Biology/Neuronal Signaling Mechanisms</subject><subject>Developmental Biology/Neurodevelopment</subject><subject>Neuroscience/Neuronal and Glial Cell Biology</subject><subject>Neuroscience/Neuronal Signaling Mechanisms</subject><subject>Neurological Disorders/Epilepsy</subject></subj-group></article-categories><title-group><article-title>The Pafah1b Complex Interacts with the Reelin Receptor VLDLR</article-title><alt-title alt-title-type="running-head">Pafah1b Binds Vldlr</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Guangcheng</given-names></name><xref rid="aff1" ref-type="aff"><sup>1</sup></xref><xref rid="aff2" ref-type="aff"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Assadi</surname><given-names>Amir H.</given-names></name><xref rid="aff1" ref-type="aff"><sup>1</sup></xref><xref rid="aff2" ref-type="aff"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>McNeil</surname><given-names>Robert S.</given-names></name><xref rid="aff1" ref-type="aff"><sup>1</sup></xref><xref rid="aff2" ref-type="aff"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Beffert</surname><given-names>Uwe</given-names></name><xref rid="aff7" ref-type="aff"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wynshaw-Boris</surname><given-names>Anthony</given-names></name><xref rid="aff8" ref-type="aff"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Herz</surname><given-names>Joachim</given-names></name><xref rid="aff7" ref-type="aff"><sup>7</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Clark</surname><given-names>Gary D.</given-names></name><xref rid="aff1" ref-type="aff"><sup>1</sup></xref><xref rid="aff2" ref-type="aff"><sup>2</sup></xref><xref rid="aff3" ref-type="aff"><sup>3</sup></xref><xref rid="aff4" ref-type="aff"><sup>4</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>D'Arcangelo</surname><given-names>Gabriella</given-names></name><xref rid="aff1" ref-type="aff"><sup>1</sup></xref><xref rid="aff2" ref-type="aff"><sup>2</sup></xref><xref rid="aff3" ref-type="aff"><sup>3</sup></xref><xref rid="aff5" ref-type="aff"><sup>5</sup></xref><xref rid="aff6" ref-type="aff"><sup>6</sup></xref><xref ref-type="corresp" rid="n101"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>The Cain Foundation Laboratories, Texas Children's Hospital, Houston, Texas, United States of America</addr-line></aff><aff id="aff2"><addr-line>Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America</addr-line></aff><aff id="aff3"><addr-line>Department of Neuroscience, Baylor College of Medicine, Houston, Texas, United States of America</addr-line></aff><aff id="aff4"><addr-line>Department of Neurology, Baylor College of Medicine, Houston, Texas, United States of America</addr-line></aff><aff id="aff5"><addr-line>Program in Developmental Biology, Baylor College of Medicine, Houston, Texas, United States of America</addr-line></aff><aff id="aff6"><addr-line>Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, United States of America</addr-line></aff><aff id="aff7"><addr-line>Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America</addr-line></aff><aff id="aff8"><addr-line>Department of Pediatrics and Medicine, University of California, San Diego School of Medicine, La Jolla, California, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Mueller</surname><given-names>Ulrich</given-names></name><role>Academic Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">University of Giessen, Germany</aff><author-notes><corresp id="n101">&#x0002a; To whom correspondence should be addressed. E-mail: <email>gangelo@bcm.tmc.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: GC GD. Performed the experiments: GZ AA UB GZ. Analyzed the data: RM. Contributed reagents/materials/analysis tools: JH AW AW. Wrote the paper: GD.</p></fn></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>28</day><month>2</month><year>2007</year></pub-date><volume>2</volume><issue>2</issue><elocation-id>e252</elocation-id><history><date date-type="received"><day>16</day><month>1</month><year>2007</year></date><date date-type="accepted"><day>30</day><month>1</month><year>2007</year></date></history><copyright-statement>Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2007</copyright-year><abstract><p>Reelin is an extracellular protein that directs the organization of cortical structures of the brain through the activation of two receptors, the very low-density lipoprotein receptor (VLDLR) and the apolipoprotein E receptor 2 (ApoER2), and the phosphorylation of Disabled-1 (Dab1). Lis1, the product of the <italic>Pafah1b1</italic> gene, is a component of the brain platelet-activating factor acetylhydrolase 1b (Pafah1b) complex, and binds to phosphorylated Dab1 in response to Reelin. Here we investigated the involvement of the whole Pafah1b complex in Reelin signaling and cortical layer formation and found that catalytic subunits of the Pafah1b complex, Pafah1b2 and Pafah1b3, specifically bind to the NPxYL sequence of VLDLR, but not to ApoER2. Compound <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic>;<italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> mutant mice exhibit a <italic>reeler</italic>-like phenotype in the forebrain consisting of the inversion of cortical layers and hippocampal disorganization, whereas double <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic>;<italic>Vldlr<sup>&#x02212;/&#x02212;</sup></italic> mutants do not. These results suggest that a cross-talk between the Pafah1b complex and Reelin occurs downstream of the VLDLR receptor.</p></abstract><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Heterozygous mutations in the <italic>PAFAH1B1</italic> (<italic>LIS1</italic>) gene in humans causes a reduction in the number of cortical gyri (lissencephaly) <xref ref-type="bibr" rid="pone.0000252-Reiner1">&#x0005b;1&#x0005d;</xref>. Homozygous mutations in the <italic>REELIN</italic> (<italic>RELN</italic>) gene also result in lissencephaly, with additional cerebellar hypoplasia <xref ref-type="bibr" rid="pone.0000252-Hong1">&#x0005b;2&#x0005d;</xref>. Reelin, a secreted glycoprotein controlling neuronal positioning, functions by clustering its receptors VLDLR and ApoER2, causing the activation of src-family kinases (SRKs) and the phosphorylation of the adapter molecule Dab1 (reviewed by <xref ref-type="bibr" rid="pone.0000252-Rice1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000252-DArcangelo1">&#x0005b;5&#x0005d;</xref>). Disruption of <italic>Reelin</italic> (<italic>Reln</italic>) in homozygous <italic>reeler</italic> mice results in cortical layer disruption, cerebellar hypoplasia and ataxia. Mice deficient for Dab1 <xref ref-type="bibr" rid="pone.0000252-Howell1">&#x0005b;6&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000252-Ware1">&#x0005b;8&#x0005d;</xref>, both VLDLR and ApoER2 receptors <xref ref-type="bibr" rid="pone.0000252-Trommsdorff1">&#x0005b;9&#x0005d;</xref> and SFKs Fyn and Src <xref ref-type="bibr" rid="pone.0000252-Kuo1">&#x0005b;10&#x0005d;</xref> exhibit a <italic>reeler</italic>-like phenotype.</p><p>Homozygous deletions of the <italic>Pafah1b1</italic> gene (encoding Lis1) in the mouse result in early embryonic lethality, whereas heterozygous mutations lead to hippocampal lamination defects <xref ref-type="bibr" rid="pone.0000252-Hirotsune1">&#x0005b;11&#x0005d;</xref>. Further reduction of Lis1 activity in compound hypomorphic mutants led to the disruption of cortical layers <xref ref-type="bibr" rid="pone.0000252-Gambello1">&#x0005b;12&#x0005d;</xref>. Lis1 was initially identified as the non-catalytic &#x003b2; subunit of the Pafah1b complex <xref ref-type="bibr" rid="pone.0000252-Reiner1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Hattori1">&#x0005b;13&#x0005d;</xref>. This complex also contains two catalytic &#x003b1; subunits encoded by the <italic>Pafah1b2</italic> and <italic>Pafah1b3</italic> genes that hydrolyze the platelet-activating factor <xref ref-type="bibr" rid="pone.0000252-Albrecht1">&#x0005b;14&#x0005d;</xref>. The product of the <italic>Pafah1b2</italic> gene (&#x003b1;2) is 30 kDa, whereas the product of the <italic>Pafah1b3</italic> gene (&#x003b1;1) is a 29 kDa protein. The entire Pafah1b complex resembles a G-protein signaling complex <xref ref-type="bibr" rid="pone.0000252-Ho1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Yan1">&#x0005b;16&#x0005d;</xref>. In the mouse, mutations in the &#x003b1; subunit genes cause no overt neurological phenotype, but loss of Pafah1b2 disrupts spermatogenesis <xref ref-type="bibr" rid="pone.0000252-Yan1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Koizumi1">&#x0005b;17&#x0005d;</xref>. In humans, <italic>PAFAH1B3</italic> hemizygousity is associated with mental retardation and ataxia <xref ref-type="bibr" rid="pone.0000252-Nothwang1">&#x0005b;18&#x0005d;</xref>, suggesting that the catalytic subunits of Pafah1b may be important for brain development or function. In addition to its involvement with the Pafah1b complex, Lis1 participates in cytoskeletal dynamics as a component of an evolutionary conserved pathway that mediates nucleokinesis (reviewed by <xref ref-type="bibr" rid="pone.0000252-WynshawBoris1">&#x0005b;19&#x0005d;</xref>). Lis1 regulates the function of cytoplasmic dynein/dynactin motor complex <xref ref-type="bibr" rid="pone.0000252-Faulkner1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Smith1">&#x0005b;21&#x0005d;</xref> through binding to several of its components. These interactions are thought to be important for several aspects of brain development, including neural stem cell proliferation and neuronal migration <xref ref-type="bibr" rid="pone.0000252-Tsai1">&#x0005b;22&#x0005d;</xref>.</p><p>We previously showed that Lis1 binds Dab1 in a Reelin-dependent manner and that Lis1 and Reelin functionally interact <xref ref-type="bibr" rid="pone.0000252-Assadi1">&#x0005b;23&#x0005d;</xref>. Given the association of Lis1 with the Pafah1b &#x003b1; subunits, we investigated the interaction between this complex and the Reelin pathway. Here we demonstrated that both &#x003b1; subunits bind the Reelin receptor VLDLR but not ApoER2. Genetic experiments further demonstrated that loss of ApoER2 combined with Lis1 reduction results in a <italic>reeler</italic>-like phenotype, suggesting that the Pafah1b complex modulates the Reelin pathway.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Pafah1b3 and Pafah1b2 bind to VLDLR but not to ApoER2</title><p>Previous observations revealed the genetic interaction of <italic>Pafah1b1</italic> with the genes encoding components of the <italic>Reln</italic> signaling pathway, and the direct binding of Lis1 to phosphorylated Dab1 <xref ref-type="bibr" rid="pone.0000252-Assadi1">&#x0005b;23&#x0005d;</xref>. In this study we turned our attention to the catalytic &#x003b1; subunits of the Pafah1b complex. To investigate potential biochemical interactions of Pafah1b &#x003b1; subunits with the Reelin receptors VLDLR and ApoER2, co-immunoprecipitation assays were performed. Plasmids encoding Pafah1b3 (tagged with a MYC epitope) and VLDLR (tagged with either GFP or HA epitopes) were transfected in 293T cells. Results show that VLDLR was co-immunoprecipitated with antibodies directed against the Pafah1b3 tag and, conversely, that Pafah1b3 was co-immunoprecipitated with antibodies directed against the VLDLR tag (<xref ref-type="fig" rid="pone-0000252-g001">Fig. 1A</xref>). To determine whether this binding was direct, individual FLAG-tagged Pafah1b subunits were expressed in a cell-free system and incubated in the presence of <italic>in vitro</italic>- translated VLDLR. The receptor was efficiently co-immunoprecipitated with either Pafah1b2 or Pafah1b3, but not with Lis1 (<xref ref-type="fig" rid="pone-0000252-g001">Fig. 1B</xref>), indicating that the &#x003b1; subunits are capable of binding VLDLR directly.</p><p>Similar experiments were performed to determine whether Pafah1b3 and Pafah1b2 interact with ApoER2. When this receptor was co-expressed with either Pafah1b2 or Pafah1b3 in 293T cells, immunoprecipitation experiments failed to reveal any interaction (<xref ref-type="fig" rid="pone-0000252-g001">Fig. 1C</xref>). As a positive control we used Dab1, which is known to bind lipoprotein receptors <xref ref-type="bibr" rid="pone.0000252-Trommsdorff1">&#x0005b;9&#x0005d;</xref>. Immunoprecipitation assays using <italic>in vitro</italic> translated proteins also revealed no interaction between &#x003b1; subunits and ApoER2, whereas Dab1 was able to bind the receptor, as expected (<xref ref-type="fig" rid="pone-0000252-g001">Fig. 1D</xref>). Together, these results demonstrate that both Pafah1b2 and Pafah1b3 &#x003b1; subunits interact specifically with the Reelin receptor VLDLR, but not with ApoER2.</p><p>The cytoplasmic NPxY domain of lipoprotein receptors enables binding of proteins containing PTB domains such as Dab1 <xref ref-type="bibr" rid="pone.0000252-Trommsdorff1">&#x0005b;9&#x0005d;</xref>. To determine whether the NPxY motif is required for Pafah1b2 and Pafah1b3 binding to VLDLR, a series of C terminal truncation mutants of the receptor tagged with GFP were produced (<xref ref-type="fig" rid="pone-0000252-g002">Fig. 2A</xref>). Co-immunoprecipitation experiments were conducted in COS7 cells using antibodies against the &#x003b1; subunit tag. The VLDLR ectodomain fragment (VLDLR&#x00394;809) and the C-terminal truncation mutant VLDLR&#x00394;825, both lacking the NPxY domain, showed no interaction with Pafah1b3 (<xref ref-type="fig" rid="pone-0000252-g002">Fig. 2B</xref>) or with Pafah1b2 (<xref ref-type="fig" rid="pone-0000252-g002">Fig. 2D</xref>). On the other hand, the truncation construct VLDLR&#x00394;855 that retained the NPxY motif did exhibit binding to Pafah1b3 (<xref ref-type="fig" rid="pone-0000252-g002">Fig. 2B and C</xref>) and to Pafah1b2 (<xref ref-type="fig" rid="pone-0000252-g002">Fig. 2D</xref>). Finally, the specific NPxY mutant, VLDLR(AAxA), showed loss of interaction with either Pafah1b3 (<xref ref-type="fig" rid="pone-0000252-g002">Fig. 2C</xref>) and with Pafah1b2 (<xref ref-type="fig" rid="pone-0000252-g002">Fig. 2D</xref>). These results demonstrated that &#x003b1; subunit binding to VLDLR requires the presence of an intact NPxY motif.</p><p>The cytoplasmic regions of VLDLR and ApoER2 that include the NPxY binding domain possess significant sequence homology, yet we found that Pafah1b2 and Pafah1b3 bind only to VLDLR. To understand this apparent discrepancy, we examined the protein sequence of the receptor intracellular domains. The NPxY motif sequence in both receptors is NPVY, but the first amino acid downstream of this motif differs. In VLDLR this residues corresponds to a leucine (Leu<sup>838</sup>), whereas in ApoER2 is an arginine (Arg<sup>774</sup>) (<xref ref-type="fig" rid="pone-0000252-g003">Fig. 3A</xref>). To determine whether a leucine at this position is important for Pafah1b2 and Pafah1b3 binding, an ApoER2 mutant receptor was generated in which Arg<sup>774</sup> was substituted by a leucine (R774L). Co-immunoprecipitation experiments in transfected cells demonstrated that ApoER2 carrying the R774L mutation was able to bind Pafah1b2 and Pafah1b3, unlike the wild type receptor (<xref ref-type="fig" rid="pone-0000252-g003">Fig. 3B</xref>). These observations suggest that the NPVY<underline>L</underline> sequence of VLDLR mediates its unique property of binding to the Pafah1b &#x003b1; subunits. In contrast, Dab1 does not appear to discriminate between lipoprotein receptors as it binds to both, the NPVYL sequence of VLDLR and the NPVYR sequence of ApoER2.</p><p>Since the Pafah1b &#x003b1; subunits and Dab1 bind a similar region of VLDLR, we reasoned that they might compete for receptor occupancy. Indeed, increasing concentrations of Pafah1b2 were found to displace Pafah1b3 from VLDLR in co-immunoprecipitation experiments <italic>in vitro</italic> (<xref ref-type="fig" rid="pone-0000252-g004">Fig. 4A</xref>). Furthermore, increasing concentrations of Pafah1b3 were able to partially displace Dab1 from VLDLR, consistently with our observation that they bind similar residues of the receptor intracellular domain (<xref ref-type="fig" rid="pone-0000252-g004">Fig. 4B</xref>).</p></sec><sec id="s2b"><title>In vivo analysis of the Pafah1b complex function in cortical lamination</title><p>The biochemical data presented above suggests that the &#x003b1; subunits may bring the whole Pafah1b complex in proximity of the VLDLR receptor. Since this receptor also binds Dab1, our findings raised the possibility that the Pafah1b complex may modulate Reelin signaling. To address this possibility <italic>in vivo</italic>, we set out to generate double mutant mice carrying mutations in genes encoding Pafah1b subunits as well as in genes encoding Reelin receptors. Given that both, <italic>Apoer2</italic> and <italic>Pafah1b2</italic> male knock out mice are sterile <xref ref-type="bibr" rid="pone.0000252-Yan1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Andersen1">&#x0005b;24&#x0005d;</xref>, we could not generate double mutants that lacked these proteins. We were however able to readily generate compound mice that were heterozygous for <italic>Pafah1b1</italic> and homozygous for either <italic>Apoer2</italic> or <italic>Vldlr</italic>. Cortical lamination in these mutants was analyzed as a read-out of Reelin activity in brain development and compared to single mutants or to double <italic>Apoer2</italic>/<italic>Vldlr</italic> mutants, which exhibit a <italic>reeler</italic>-like phenotype. Cortical sections were stained with two cellular layer-specific neuronal markers, Calbindin (layer II/III) and Foxp2 (layer VI) and the layer distribution of immunolabeled cells was analyzed quantitatively. This analysis revealed no obvious lamination defects in single <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup> or <italic>Vldlr</italic><sup>&#x02212;/&#x02212;</sup> mice, whereas some layer abnormalities were observed in single <italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup> mice, as previously reported <xref ref-type="bibr" rid="pone.0000252-Trommsdorff1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Benhayon1">&#x0005b;25&#x0005d;</xref> (<xref ref-type="fig" rid="pone-0000252-g005">Fig. 5</xref>). The cortex of <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup>;<italic>Vldlr</italic><sup>&#x02212;/&#x02212;</sup> double mutants also appear fairly normal, however, that of <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup>;<italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup> double mutants presented a severe abnormality similar to the cortical layer inversion typically seen in <italic>Reln</italic><sup>&#x02212;/&#x02212;</sup>, <italic>Dab1</italic><sup>&#x02212;/&#x02212;</sup> or <italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup><italic>;Vldlr</italic><sup>&#x02212;/&#x02212;</sup> mutants (<xref ref-type="fig" rid="pone-0000252-g005">Fig. 5</xref>). Calbindin-positive neurons destined for upper layers were ectopically located in the lower cortex, whereas Foxp2-positive neurons destined for a lower layer were ectopically located into the upper cortex. The cortex of <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup>;<italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup> mutants also revealed hypercellularity of layer I, another typical feature of the <italic>reeler</italic> phenotype that is also seen in double <italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup><italic>;Vldlr</italic><sup>&#x02212;/&#x02212;</sup> mutants (<xref ref-type="fig" rid="pone-0000252-g005">Fig. 5</xref>).</p><p>To gain further evidence of the occurrence of a <italic>reeler</italic>-like phenotype in <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup>;<italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup> double mutants, we also examined the anatomy of hippocampal structures (<xref ref-type="fig" rid="pone-0000252-g006">Fig. 6</xref>). Cellular layers in the hippocampus proper and dentate gyrus were normal in heterozygous <italic>Apoer2</italic><sup>&#x0002b;/&#x02212;</sup> mice, whereas a modest split of the pyramidal layer in area CA1 and CA3 was observed in <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup> and homozygous <italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup> mice. However, a <italic>reeler</italic>-like phenotype characterized by profound dyslamination of all cellular layers was observed in double <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup>;<italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="pone-0000252-g006">Fig. 6</xref>). No gross abnormalities were observed in the cerebellum of <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup>;<italic>Apoer2</italic><sup>&#x02212;/&#x02212;</sup> double mutants, unlike <italic>reeler</italic> mice which exhibit profound cerebellar hypoplasia (not shown). Together, these data demonstrate that <italic>Pafah1b1</italic>, like <italic>Vldlr</italic> mutations, synergize with <italic>Apoer2</italic> disruption and contribute to the appearance of a <italic>reeler</italic>-like phenotype, at least in the forebrain.</p></sec><sec id="s2c"><title>Reelin signaling is largely intact in Pafah1b1<sup>&#x0002b;/&#x02212;</sup>; Apoer2<sup>&#x02212;/&#x02212;</sup> cortical neurons</title><p>In normal neurons, Reelin treatment induces Dab1 phosphorylation on tyrosine residues <xref ref-type="bibr" rid="pone.0000252-Howell2">&#x0005b;26&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000252-Ballif1">&#x0005b;28&#x0005d;</xref> and the activation of PI3K, which leads to the phosphorylation of Akt on serine residue 473 <xref ref-type="bibr" rid="pone.0000252-Beffert1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000252-Ballif2">&#x0005b;31&#x0005d;</xref>. In double <italic>Vldlr<sup>&#x02212;/&#x02212;</sup>;Apoer2<sup>&#x02212;/&#x02212;</sup></italic> mutant mice the appearance of the anatomical phenotype correlates with loss of these Reelin-dependent signaling events <xref ref-type="bibr" rid="pone.0000252-Beffert1">&#x0005b;29&#x0005d;</xref>. Since double <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup>; Apoer2</italic><sup>&#x02212;/&#x02212;</sup> mutants exhibit a <italic>reeler</italic>-like phenotype in the forebrain, we sought to determine whether Reelin signaling was also affected. Cortical neurons were obtained from mice carrying <italic>Pafah1b1, Apoer2</italic> and <italic>Vldlr</italic> mutations, alone or in combination. As for normal mice, Reelin treatment was found to induce Dab1 and Akt phosphorylation in all mutants examined, including <italic>Pafah1b1</italic><sup>&#x0002b;/&#x02212;</sup><italic>;Apoer2</italic><sup>&#x02212;/&#x02212;</sup> mutants, even though these animals exhibit cortical layers defects (<xref ref-type="fig" rid="pone-0000252-g007">Fig. 7</xref>). These data indicate Dab1 and Akt phosphorylation is not sufficient to induce cortical layer formation.</p></sec></sec><sec id="s3"><title>Discussion</title><p>We have previously demonstrated the existence of an interaction between Reelin and Lis1 signaling consisting of the direct binding of Lis1, the regulatory subunit of the Pafah1b complex, to the adapter Dab1 <xref ref-type="bibr" rid="pone.0000252-Assadi1">&#x0005b;23&#x0005d;</xref>. This interaction takes place when Dab1 is phosphorylated on tyrosine residues in response to Reelin. In the present study we have examined the interaction of individual Reelin receptors with the subunits of the Pafah1b complex. We shown that the catalytic &#x003b1; subunits of the Pafah1b complex, Pafah1b2 and Pafah1b3, bind specifically VLDLR and that a reduction in Lis1 activity mimics the loss of this receptor in the forebrain. The binding of Pafah1b3 and Pafah1b2 to VLDLR requires the NPxY domain and the presence of a leucine residue immediately following this sequence. The catalytic &#x003b1; subunits cannot bind the NPxYR sequence of ApoER2, but a point mutation that converts the arginine residue adjacent to the NPxY motif to a leucine rescued Pafah1b &#x003b1; subunit binding, demonstrating that this residue is critical for coupling the Pafah1b complex selectively with VLDLR. Given the low abundance of this receptor in neurons, we could not confirm that the interactions we observed in transfected cells and <italic>in vitro</italic> also take place in normal neurons. However, given the specificity of the Pafah1b &#x003b1; subunits for VLDLR and the strict requirement for the NPVYL sequence, it seems reasonable to conclude that the binding may indeed occur <italic>in vivo</italic>.</p><p>Through our genetic studies, we demonstrated that the biochemical interaction of the Pafah1b complex with VLDLR has physiological consequences for forebrain development. Consistent with our biochemical data, we observed that <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic> mutations had no effect on the appearance of brain structures in <italic>Vldlr<sup>&#x02212;/&#x02212;</sup></italic> mutants, suggesting that the products of these genes may function in a linear pathway. On the other hand <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic> mutations exacerbated the phenotype of <italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> mutants to an extent that the appearance of cortical and hippocampal structures in double <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic>; <italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> mutants resembled that of <italic>reeler</italic> mice. Since a <italic>reeler</italic>-like phenotype is also observed in double <italic>Vldlr<sup>&#x02212;/&#x02212;</sup></italic>; <italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> mutants <xref ref-type="bibr" rid="pone.0000252-Trommsdorff1">&#x0005b;9&#x0005d;</xref>, these data suggest that Lis1 is an important component of the Reelin signaling pathway downstream of VLDLR (<xref ref-type="fig" rid="pone-0000252-g008">Fig. 8</xref>). The simplest interpretation of our data is that the &#x003b1; subunits function as signaling adapter molecules by bringing Lis1 in proximity of the VLDLR receptor and Dab1, thus facilitating Reelin signaling through this receptor. An alternative interpretation of our genetic findings is that ApoER2 is the dominant Reelin receptor in forebrain development, and that the consequences of <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic> mutations on Reelin signaling can only be appreciated when this receptor is missing. This view is supported by the observation that <italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> mutations in isolation already result in a noticeable cortical and hippocampal phenotype, unlike <italic>Vldlr<sup>&#x02212;/&#x02212;</sup></italic> mutations <xref ref-type="bibr" rid="pone.0000252-Trommsdorff1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Benhayon1">&#x0005b;25&#x0005d;</xref>. Both interpretations of our data are consistent with a functional role for the Pafah1b complex in Reelin signaling during brain development.</p><p>Despite the disorganization of cortical layers, we observed that the induction of Dab1 and Akt phosphorylation by Reelin was fairly normal in neurons isolated from <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic>; <italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> double mutant brains. This is in striking contrast to the results obtained using <italic>Vldlr<sup>&#x02212;/&#x02212;</sup></italic>; <italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> double mutant neurons, in which Reelin does not appear capable to elicit any signaling events <xref ref-type="bibr" rid="pone.0000252-Benhayon1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Beffert1">&#x0005b;29&#x0005d;</xref>. Similarly, Reelin treatment did not induce Akt phosphorylation in <italic>Dab1</italic><sup>&#x02212;/&#x02212;</sup> neurons <xref ref-type="bibr" rid="pone.0000252-Beffert1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Ballif2">&#x0005b;31&#x0005d;</xref>. Our findings indicate that the Pafah1b complex and Lis1 are not required for many of the signaling events which are normally stimulated by Reelin mainly through clustering of the ApoER2 receptor. In the absence of ApoER2, Reelin signaling events such as Dab1 and Akt phosphorylation still occur, albeit to a lower level, mediated by the VLDLR receptor and irrespective of the presence of Pafah1b proteins. However, under these reduced signaling conditions, Lis1 deficiency prevents the formation of cortical layers. Together with our previous observation that Lis1 binds exclusively phospho-Dab1 <xref ref-type="bibr" rid="pone.0000252-Assadi1">&#x0005b;23&#x0005d;</xref>, the present findings suggest that Lis1 functions downstream of SFK activity and it is not predicted to interfere with the interaction between Dab1 and other signaling molecules such as PI3K <xref ref-type="bibr" rid="pone.0000252-Beffert1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000252-Ballif2">&#x0005b;31&#x0005d;</xref>, Nck&#x003b2; <xref ref-type="bibr" rid="pone.0000252-Pramatarova1">&#x0005b;32&#x0005d;</xref>, Crk family proteins <xref ref-type="bibr" rid="pone.0000252-Ballif1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Huang1">&#x0005b;33&#x0005d;</xref>, or N-WASP <xref ref-type="bibr" rid="pone.0000252-Suetsugu1">&#x0005b;34&#x0005d;</xref>.</p><p>We and others have previously shown that loss of Pafah1b &#x003b1; subunits in the mouse does not result in a neurological phenotype, but affects spermatogenesis <xref ref-type="bibr" rid="pone.0000252-Yan1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Koizumi1">&#x0005b;17&#x0005d;</xref>. These studies indicate that the catalytic subunits of the Pafah1b complex are not absolutely required for brain development. Based on the present data we propose that they may modulate Reelin signaling downstream of VLDLR, possibly by promoting Lis1 and Dab1 interaction.</p><p>VLDLR and ApoER2 are both individually capable of binding Reelin on the extracellular side and Dab1 on the intracellular side, and both contribute to cortical layer formation <xref ref-type="bibr" rid="pone.0000252-Trommsdorff1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Benhayon1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-DArcangelo2">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000252-Hiesberger1">&#x0005b;36&#x0005d;</xref>. In addition, ApoER2 is known to bind JNK Interacting Protein (JIP) 1 and 2 and PSD-95 through a unique intracellular domain encoded by an alternatively spliced exon <xref ref-type="bibr" rid="pone.0000252-Stockinger1">&#x0005b;37&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000252-Brandes1">&#x0005b;39&#x0005d;</xref>. Recent studies demonstrated that ApoER2 interacts with the NMDA receptor, thereby mediating a Reelin-dependent function in learning and memory in the adult brain <xref ref-type="bibr" rid="pone.0000252-Beffert2">&#x0005b;40&#x0005d;</xref>. Here we have shown that VLDLR is also capable of unique interactions that may affect Reelin signaling and forebrain cellular layer formation. It has recently been reported that <italic>VLDLR</italic> deletions in humans result in a neurological disorder characterized by lissencephaly and cerebellar hypoplasia, malformations similar but less severe than those associated with <italic>RELN</italic> deletions <xref ref-type="bibr" rid="pone.0000252-Boycott1">&#x0005b;41&#x0005d;</xref>. Thus, in humans an overt neurological phenotype is seen even in the presence of the ApoER2, further underscoring the importance of VLDLR in brain development. It remains to be determined whether the unique ability of VLDLR to bind the Pafah1b complex affects postnatal brain function in addition to neuronal positioning during embryogenesis.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Generation of plasmid constructs</title><p>Human <italic>VLDLR</italic> cDNA encoding the 873 amino acids isoform A (accession # NP_003374) was cloned into pEGFP-N1 (Clontech) to generate the VLDLR-GFP fusion protein. Alternatively, the same cDNA was tagged at the C terminus with the HA epitope by PCR. Truncation constructs VLDLR&#x00394;809-GFP (containing VLDLR amino acids 1-809), VLDLR&#x00394;825-GFP (containing VLDLR amino acids 1-825) and VLDLR&#x00394;855-GFP (containing VLDLR amino acids 1-855) were generated using the Expand High Fidelity PCR System. To produce VLDLR(AAxA)-GFP, site directed mutagenesis was performed on the VLDLR-GFP plasmid using the Stratagene QuickChange Mutagenesis Kit. Mouse <italic>Apoer2</italic> cDNA (a gift from J. Nimpf, Medical University of Vienna, Austria) encoding the full-length receptor (accession # CAC38356) minus the alternatively spliced 59 amino acids exon 19 was cloned in frame with GFP or HA as described above for VLDLR. The FLAG-ApoER2(WT) construct was generated by subcloning ApoER2-HA into pCMV-Tag (Stratagene). This construct was further mutagenized to generate the FLAG- ApoER2(R774L) in which Arg residue 774 is replaced by a Leu. All constructs were sequenced to verify the intended mutations. Mouse <italic>Dab1</italic> cDNA (accession # NP_796233) encoding the 555 amino acids isoform 2 was HA-tagged by PCR and subcloned into pcDNA3.1 vector (Invitrogen). Mouse <italic>Pafah1b3</italic> cDNA (accession #Q61205) encoding the 29 kDa &#x003b1;1 subunit, mouse <italic>Pafah1b2</italic> cDNA (accession # Q61206) encoding the 30 kDa &#x003b1;2 subunit, and mouse <italic>Pafah1b1</italic> cDNA (accession #NP_038653) encoding the 45 kDa &#x003b2;1 subunit of the Pafah1b complex, were cloned into the pEGFP-C1 (Clontech), pcDNA3.1(&#x0002b;)-myc/his (Invitrogen) or pCMV-Tag (Stratagene) to introduce the GFP, Myc or FLAG tag, respectively.</p></sec><sec id="s4b"><title>Cell culture and protein analysis</title><p>COS7 or 293T cells (ATCC) were cultured in DMEM supplemented with 10&#x00025; fetal bovine serum, and transfected with expression vectors using the Fugene 6 reagent (Roche). After 30&#x02013;40 hours, the cells were harvested and the proteins extracted in lysis buffer (PBS, 5 mM EDTA, 1&#x00025; Triton X-100, pH 7.4) in the presence of protease inhibitors (Mini Complete protease inhibitor cocktail tablets, Roche). For immunoprecipitation, the lysates were incubated with appropriate antibodies for 1&#x02013;2 hours at 4&#x000b0;C, followed by protein A/G agarose beads (Pierce). Samples were analyzed by SDS-PAGE. To assay Reelin signaling, primary cortical neurons were cultured from embryonic mice and treated with Reelin-containing conditioned medium for 20 min. Cells were lysed and proteins were subjected to Western blot analysis as previously described <xref ref-type="bibr" rid="pone.0000252-Beffert1">&#x0005b;29&#x0005d;</xref>.</p></sec><sec id="s4c"><title>In vitro binding assay</title><p><italic>Vldlr, Apoer2, Pafah1b1, Pafah1b3, Pafah1b2,</italic> and <italic>Dab1</italic> cDNAs were produced <italic>in vitro</italic> using the TNT Quick Coupled Transcription/Translation System (Promega), according to the manufacturer instructions using <sup>35</sup>S-labeled methionine (Amersham Biosciences). Proteins were separated by SDS-PAGE and detected by autoradiography on dried gels. Quantitative analysis of autoradiography bands density was performed using ImageJ software (NIH image).</p></sec><sec id="s4d"><title>Animals</title><p><italic>Reeler</italic> mutant mice were obtained from The Jackson Laboratories on a C57BL/6&#x000d7;C3H hybrid background. <italic>Vldlr, Apoer2</italic> and <italic>Dab1</italic> knock out mice were on a hybrid C57BL/6&#x000d7;129S6/SvEv. <italic>Pafah1b1</italic> (<italic>Pafah1b1<sup>neo</sup></italic>, a null, was utilized in these studies) <xref ref-type="bibr" rid="pone.0000252-Hirotsune1">&#x0005b;11&#x0005d;</xref> was on a 129S6/SvEv background. Mutants were genotyped by PCR as described previously for <italic>Pafah1b1</italic><xref ref-type="bibr" rid="pone.0000252-Hirotsune1">&#x0005b;11&#x0005d;</xref>, <italic>Reelin</italic><xref ref-type="bibr" rid="pone.0000252-Niu1">&#x0005b;42&#x0005d;</xref>, <italic>Apoer2</italic> and <italic>Vldlr</italic><xref ref-type="bibr" rid="pone.0000252-Trommsdorff1">&#x0005b;9&#x0005d;</xref>, and <italic>Dab1</italic><xref ref-type="bibr" rid="pone.0000252-Howell1">&#x0005b;6&#x0005d;</xref>.</p></sec><sec id="s4e"><title>Quantification and statistical analysis of cortical sections</title><p>Sagittal paraffin sections (5 &#x000b5;m) of the brain from siblings (when possible) of each genotype were stained with cresyl violet or processed for immunohistochemistry using antibodies against Calbindin (layer II&#x02013;III) or Foxp2 (layer VI). Four paramedian sagittal images at a level caudal to the corpus callosum were utilized for quantitative analysis as previously described <xref ref-type="bibr" rid="pone.0000252-Assadi1">&#x0005b;23&#x0005d;</xref>.</p></sec></sec></body><back><ack><p>We thank T. Curran and J. Nimpf for plasmid constructs, G. Eichele for <italic>Pafah1b3</italic> mutant mice, B.A. Antalffy for help with histology.</p></ack><ref-list><title>References</title><ref id="pone.0000252-Reiner1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>O</given-names></name><name><surname>Carrozzo</surname><given-names>R</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Wehnert</surname><given-names>M</given-names></name><name><surname>Faustinella</surname><given-names>F</given-names></name><etal/></person-group><year>1993</year><article-title>Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats.</article-title><source>Nature</source><volume>364</volume><fpage>717</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">8355785</pub-id></citation></ref><ref id="pone.0000252-Hong1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>SE</given-names></name><name><surname>Shugart</surname><given-names>YY</given-names></name><name><surname>Huang</surname><given-names>DT</given-names></name><name><surname>Al Shahwan</surname><given-names>S</given-names></name><name><surname>Grant</surname><given-names>PE</given-names></name><etal/></person-group><year>2000</year><article-title>Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations.</article-title><source>Nature Genet</source><volume>26</volume><fpage>93</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">10973257</pub-id></citation></ref><ref id="pone.0000252-Rice1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>DS</given-names></name><name><surname>Curran</surname><given-names>T</given-names></name></person-group><year>2001</year><article-title>Role of the Reelin signaling pathway in central nervous system development.</article-title><source>Ann Rev Neurosci</source><volume>24</volume><fpage>1005</fpage><lpage>1039</lpage><pub-id pub-id-type="pmid">11520926</pub-id></citation></ref><ref id="pone.0000252-Tissir1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tissir</surname><given-names>F</given-names></name><name><surname>Goffinet</surname><given-names>AM</given-names></name></person-group><year>2003</year><article-title>Reelin and brain development.</article-title><source>Nat Rev Neurosci</source><volume>4</volume><fpage>496</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">12778121</pub-id></citation></ref><ref id="pone.0000252-DArcangelo1"><label>5</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>D'Arcangelo</surname><given-names>G</given-names></name></person-group><year>2005</year><article-title>The reeler mouse: anatomy of a mutant.</article-title><person-group person-group-type="editor"><name><surname>Dhossche</surname><given-names>DM</given-names></name></person-group><source>International Review of Neurobiology.</source><publisher-loc>San Diego, CA</publisher-loc><publisher-name>Elsevier Inc</publisher-name><fpage>383</fpage><lpage>417</lpage></citation></ref><ref id="pone.0000252-Howell1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>BW</given-names></name><name><surname>Hawkes</surname><given-names>R</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name></person-group><year>1997</year><article-title>Neuronal position in the developing brain is regulated by mouse disabled-1.</article-title><source>Nature</source><volume>389</volume><fpage>733</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">9338785</pub-id></citation></ref><ref id="pone.0000252-Sheldon1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheldon</surname><given-names>M</given-names></name><name><surname>Rice</surname><given-names>DS</given-names></name><name><surname>D'Arcangelo</surname><given-names>G</given-names></name><name><surname>Yoneshima</surname><given-names>H</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><etal/></person-group><year>1997</year><article-title><italic>Scrambler</italic> and <italic>yotari</italic> disrupt the <italic>disabled</italic> gene and produce a <italic>reeler</italic>-like phenotype in mice.</article-title><source>Nature</source><volume>389</volume><fpage>730</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">9338784</pub-id></citation></ref><ref id="pone.0000252-Ware1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>ML</given-names></name><name><surname>Fox</surname><given-names>JW</given-names></name><name><surname>Gonzales</surname><given-names>JL</given-names></name><name><surname>Davis</surname><given-names>NM</given-names></name><name><surname>Lambert de Rouvroit</surname><given-names>C</given-names></name><etal/></person-group><year>1997</year><article-title>Aberrant splicing of a mouse <italic>disabled</italic> homolog, <italic>mdab1</italic>, in the <italic>scrambler</italic> mouse.</article-title><source>Neuron</source><volume>19</volume><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">9292716</pub-id></citation></ref><ref id="pone.0000252-Trommsdorff1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trommsdorff</surname><given-names>M</given-names></name><name><surname>Gotthardt</surname><given-names>M</given-names></name><name><surname>Hiesberger</surname><given-names>T</given-names></name><name><surname>Shelton</surname><given-names>J</given-names></name><name><surname>Stockinger</surname><given-names>W</given-names></name><etal/></person-group><year>1999</year><article-title>Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2.</article-title><source>Cell</source><volume>97</volume><fpage>689</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">10380922</pub-id></citation></ref><ref id="pone.0000252-Kuo1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>G</given-names></name><name><surname>Arnaud</surname><given-names>L</given-names></name><name><surname>Kronstad-O'Brien</surname><given-names>P</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name></person-group><year>2005</year><article-title>Absence of Fyn and Src causes a reeler-like phenotype.</article-title><source>J Neurosci</source><volume>25</volume><fpage>8578</fpage><lpage>8586</lpage><pub-id pub-id-type="pmid">16162939</pub-id></citation></ref><ref id="pone.0000252-Hirotsune1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirotsune</surname><given-names>S</given-names></name><name><surname>Fleck</surname><given-names>MW</given-names></name><name><surname>Gambello</surname><given-names>MJ</given-names></name><name><surname>Bix</surname><given-names>GJ</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><etal/></person-group><year>1998</year><article-title>Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality.</article-title><source>Nat Genet</source><volume>19</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">9697693</pub-id></citation></ref><ref id="pone.0000252-Gambello1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gambello</surname><given-names>MJ</given-names></name><name><surname>Darling</surname><given-names>DL</given-names></name><name><surname>Yingling</surname><given-names>J</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Gleeson</surname><given-names>JG</given-names></name><etal/></person-group><year>2003</year><article-title>Multiple dose-dependent effects of Lis1 on cerebral cortical development.</article-title><source>J Neurosci</source><volume>23</volume><fpage>1719</fpage><lpage>1729</lpage><pub-id pub-id-type="pmid">12629176</pub-id></citation></ref><ref id="pone.0000252-Hattori1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>M</given-names></name><name><surname>Adachi</surname><given-names>H</given-names></name><name><surname>Tsujimoto</surname><given-names>M</given-names></name><name><surname>Arai</surname><given-names>N</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name></person-group><year>1994</year><article-title>Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase.</article-title><source>Nature</source><volume>370</volume><fpage>216</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">8028668</pub-id></citation></ref><ref id="pone.0000252-Albrecht1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albrecht</surname><given-names>U</given-names></name><name><surname>Abu-Issa</surname><given-names>R</given-names></name><name><surname>Ratz</surname><given-names>B</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name><name><surname>Aoki</surname><given-names>J</given-names></name><etal/></person-group><year>1996</year><article-title>Platelet-activating factor acetylhydrolase expression and activity suggest a link between neuronal migration and platelet-activating factor.</article-title><source>Dev Biol</source><volume>180</volume><fpage>579</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">8954729</pub-id></citation></ref><ref id="pone.0000252-Ho1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>YS</given-names></name><name><surname>Swenson</surname><given-names>L</given-names></name><name><surname>Derewenda</surname><given-names>U</given-names></name><name><surname>Serre</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><etal/></person-group><year>1997</year><article-title>Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer.</article-title><source>Nature</source><volume>385</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">8985254</pub-id></citation></ref><ref id="pone.0000252-Yan1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Assadi</surname><given-names>AH</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name><name><surname>Eichele</surname><given-names>G</given-names></name><name><surname>Matzuk</surname><given-names>MM</given-names></name><etal/></person-group><year>2003</year><article-title>Previously uncharacterized roles of platelet-activating factor acetylhydrolase 1b complex in mouse spermatogenesis.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>7189</fpage><lpage>7194</lpage><pub-id pub-id-type="pmid">12775763</pub-id></citation></ref><ref id="pone.0000252-Koizumi1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>N</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name><name><surname>Ishikawa</surname><given-names>TO</given-names></name><name><surname>Aoki</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>Targeted disruption of intracellular type I platelet activating factor-acetylhydrolase catalytic subunits causes severe impairment in spermatogenesis.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>12489</fpage><lpage>12494</lpage><pub-id pub-id-type="pmid">12551946</pub-id></citation></ref><ref id="pone.0000252-Nothwang1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nothwang</surname><given-names>HG</given-names></name><name><surname>Kim</surname><given-names>HG</given-names></name><name><surname>Aoki</surname><given-names>J</given-names></name><name><surname>Geisterfer</surname><given-names>M</given-names></name><name><surname>Kubart</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>Functional hemizygosity of PAFAH1B3 due to a PAFAH1B3-CLK2 fusion gene in a female with mental retardation, ataxia and atrophy of the brain.</article-title><source>Hum Mol Genet</source><volume>10</volume><fpage>797</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">11285245</pub-id></citation></ref><ref id="pone.0000252-WynshawBoris1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name><name><surname>Gambello</surname><given-names>MJ</given-names></name></person-group><year>2001</year><article-title>LIS1 and dynein motor function in neuronal migration and development.</article-title><source>Genes Dev</source><volume>15</volume><fpage>639</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">11274050</pub-id></citation></ref><ref id="pone.0000252-Faulkner1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>NE</given-names></name><name><surname>Dujardin</surname><given-names>DL</given-names></name><name><surname>Tai</surname><given-names>CY</given-names></name><name><surname>Vaughan</surname><given-names>KT</given-names></name><name><surname>O'Connell</surname><given-names>CB</given-names></name><etal/></person-group><year>2000</year><article-title>A role for the lissencephaly gene LIS1 in mitosis and cytoplasmic dynein function.</article-title><source>Nat Cell Biol</source><volume>2</volume><fpage>784</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">11056532</pub-id></citation></ref><ref id="pone.0000252-Smith1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>DS</given-names></name><name><surname>Niethammer</surname><given-names>M</given-names></name><name><surname>Ayala</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Gambello</surname><given-names>MJ</given-names></name><etal/></person-group><year>2000</year><article-title>Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1.</article-title><source>Nat Cell Biol</source><volume>2</volume><fpage>767</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">11056530</pub-id></citation></ref><ref id="pone.0000252-Tsai1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>JW</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name><name><surname>Vallee</surname><given-names>RB</given-names></name></person-group><year>2005</year><article-title>LIS1 RNA interference blocks neural stem cell division, morphogenesis, and motility at multiple stages.</article-title><source>J Cell Biol</source><volume>170</volume><fpage>935</fpage><lpage>945</lpage><pub-id pub-id-type="pmid">16144905</pub-id></citation></ref><ref id="pone.0000252-Assadi1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Assadi</surname><given-names>AH</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Beffert</surname><given-names>U</given-names></name><name><surname>McNeil</surname><given-names>RS</given-names></name><name><surname>Renfro</surname><given-names>AL</given-names></name><etal/></person-group><year>2003</year><article-title>Interaction of reelin signaling and Lis1 in brain development.</article-title><source>Nat Genet</source><volume>35</volume><fpage>270</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">14578885</pub-id></citation></ref><ref id="pone.0000252-Andersen1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>OM</given-names></name><name><surname>Yeung</surname><given-names>CH</given-names></name><name><surname>Vorum</surname><given-names>H</given-names></name><name><surname>Wellner</surname><given-names>M</given-names></name><name><surname>Andreassen</surname><given-names>TK</given-names></name><etal/></person-group><year>2003</year><article-title>Essential role of the apolipoprotein E receptor-2 in sperm development.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>23989</fpage><lpage>23995</lpage><pub-id pub-id-type="pmid">12695510</pub-id></citation></ref><ref id="pone.0000252-Benhayon1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benhayon</surname><given-names>D</given-names></name><name><surname>Magdaleno</surname><given-names>S</given-names></name><name><surname>Curran</surname><given-names>T</given-names></name></person-group><year>2003</year><article-title>Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1.</article-title><source>Mol Brain Res</source><volume>112</volume><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">12670700</pub-id></citation></ref><ref id="pone.0000252-Howell2"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>BW</given-names></name><name><surname>Herrick</surname><given-names>TM</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name></person-group><year>1999</year><article-title>Reelin-induced tyrosine phosphorylation of Disabled 1 during neuronal positioning.</article-title><source>Genes Dev</source><volume>13</volume><fpage>643</fpage><lpage>648</lpage><pub-id pub-id-type="pmid">10090720</pub-id></citation></ref><ref id="pone.0000252-Keshvara1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keshvara</surname><given-names>L</given-names></name><name><surname>Benhayon</surname><given-names>D</given-names></name><name><surname>Magdaleno</surname><given-names>S</given-names></name><name><surname>Curran</surname><given-names>T</given-names></name></person-group><year>2001</year><article-title>Identification of reelin-induced sites of tyrosyl phosphorylation on disabled 1.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>16008</fpage><lpage>16014</lpage><pub-id pub-id-type="pmid">11279201</pub-id></citation></ref><ref id="pone.0000252-Ballif1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballif</surname><given-names>BA</given-names></name><name><surname>Arnaud</surname><given-names>L</given-names></name><name><surname>Arthur</surname><given-names>WT</given-names></name><name><surname>Guris</surname><given-names>D</given-names></name><name><surname>Imamoto</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons.</article-title><source>Curr Biol</source><volume>14</volume><fpage>606</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">15062102</pub-id></citation></ref><ref id="pone.0000252-Beffert1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beffert</surname><given-names>U</given-names></name><name><surname>Morfini</surname><given-names>G</given-names></name><name><surname>Bock</surname><given-names>HH</given-names></name><name><surname>Reyna</surname><given-names>H</given-names></name><name><surname>Brady</surname><given-names>ST</given-names></name><etal/></person-group><year>2002</year><article-title>Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>49958</fpage><lpage>49964</lpage><pub-id pub-id-type="pmid">12376533</pub-id></citation></ref><ref id="pone.0000252-Bock1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bock</surname><given-names>HH</given-names></name><name><surname>Jossin</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Forster</surname><given-names>E</given-names></name><name><surname>May</surname><given-names>P</given-names></name><etal/></person-group><year>2003</year><article-title>PI3-Kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>38772</fpage><lpage>38779</lpage><pub-id pub-id-type="pmid">12882964</pub-id></citation></ref><ref id="pone.0000252-Ballif2"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballif</surname><given-names>BA</given-names></name><name><surname>Arnaud</surname><given-names>L</given-names></name><name><surname>Cooper</surname><given-names>JA</given-names></name></person-group><year>2003</year><article-title>Tyrosine phosphorylation of Disabled-1 is essential for Reelin-stimulated activation of Akt and Src family kinases.</article-title><source>Brain Res Mol Brain Res</source><volume>117</volume><fpage>152</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">14559149</pub-id></citation></ref><ref id="pone.0000252-Pramatarova1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pramatarova</surname><given-names>A</given-names></name><name><surname>Ochalski</surname><given-names>PG</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Gropman</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>Nck beta interacts with tyrosine-phosphorylated disabled 1 and redistributes in Reelin-stimulated neurons.</article-title><source>Mol Cell Biol</source><volume>23</volume><fpage>7210</fpage><lpage>7221</lpage><pub-id pub-id-type="pmid">14517291</pub-id></citation></ref><ref id="pone.0000252-Huang1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Magdaleno</surname><given-names>S</given-names></name><name><surname>Hopkins</surname><given-names>R</given-names></name><name><surname>Slaughter</surname><given-names>C</given-names></name><name><surname>Curran</surname><given-names>T</given-names></name><etal/></person-group><year>2004</year><article-title>Tyrosine phosphorylated Disabled 1 recruits Crk family adapter proteins.</article-title><source>Biochem Biophys Res Commun</source><volume>318</volume><fpage>204</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">15110774</pub-id></citation></ref><ref id="pone.0000252-Suetsugu1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suetsugu</surname><given-names>S</given-names></name><name><surname>Tezuka</surname><given-names>T</given-names></name><name><surname>Morimura</surname><given-names>T</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name><name><surname>Mikoshiba</surname><given-names>K</given-names></name><etal/></person-group><year>2004</year><article-title>Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1.</article-title><source>Biochem J</source><volume>384</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15361067</pub-id></citation></ref><ref id="pone.0000252-DArcangelo2"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D'Arcangelo</surname><given-names>G</given-names></name><name><surname>Homayouni</surname><given-names>R</given-names></name><name><surname>Keshvara</surname><given-names>L</given-names></name><name><surname>Rice</surname><given-names>DS</given-names></name><name><surname>Sheldon</surname><given-names>M</given-names></name><etal/></person-group><year>1999</year><article-title>Reelin is a ligand for lipoprotein receptors.</article-title><source>Neuron</source><volume>24</volume><fpage>471</fpage><lpage>479</lpage><pub-id pub-id-type="pmid">10571240</pub-id></citation></ref><ref id="pone.0000252-Hiesberger1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiesberger</surname><given-names>T</given-names></name><name><surname>Trommsdorff</surname><given-names>M</given-names></name><name><surname>Howell</surname><given-names>BW</given-names></name><name><surname>Goffinet</surname><given-names>AM</given-names></name><name><surname>Mumby</surname><given-names>MC</given-names></name><etal/></person-group><year>1999</year><article-title>Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of Disabled-1 and modulates Tau phosphorylation.</article-title><source>Neuron</source><volume>24</volume><fpage>481</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">10571241</pub-id></citation></ref><ref id="pone.0000252-Stockinger1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stockinger</surname><given-names>W</given-names></name><name><surname>Brandes</surname><given-names>C</given-names></name><name><surname>Fasching</surname><given-names>D</given-names></name><name><surname>Hermann</surname><given-names>M</given-names></name><name><surname>Gotthardt</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>25625</fpage><lpage>25632</lpage><pub-id pub-id-type="pmid">10827199</pub-id></citation></ref><ref id="pone.0000252-Gotthardt1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gotthardt</surname><given-names>M</given-names></name><name><surname>Trommsdorff</surname><given-names>M</given-names></name><name><surname>Nevitt</surname><given-names>MF</given-names></name><name><surname>Shelton</surname><given-names>J</given-names></name><name><surname>Richardson</surname><given-names>JA</given-names></name><etal/></person-group><year>2000</year><article-title>Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>25616</fpage><lpage>25624</lpage><pub-id pub-id-type="pmid">10827173</pub-id></citation></ref><ref id="pone.0000252-Brandes1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brandes</surname><given-names>C</given-names></name><name><surname>Kahr</surname><given-names>L</given-names></name><name><surname>Stockinger</surname><given-names>W</given-names></name><name><surname>Hiesberger</surname><given-names>T</given-names></name><name><surname>Schneider</surname><given-names>WJ</given-names></name><etal/></person-group><year>2001</year><article-title>Alternative splicing in the ligand binding domain of mouse ApoE receptor-2 produces receptor variants binding reelin but not alpha 2-macroglobulin.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>22160</fpage><lpage>22169</lpage><pub-id pub-id-type="pmid">11294845</pub-id></citation></ref><ref id="pone.0000252-Beffert2"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beffert</surname><given-names>U</given-names></name><name><surname>Weeber</surname><given-names>EJ</given-names></name><name><surname>Durudas</surname><given-names>A</given-names></name><name><surname>Qiu</surname><given-names>S</given-names></name><name><surname>Masiulis</surname><given-names>I</given-names></name><etal/></person-group><year>2005</year><article-title>Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor ApoER2.</article-title><source>Neuron</source><volume>47</volume><fpage>567</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">16102539</pub-id></citation></ref><ref id="pone.0000252-Boycott1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boycott</surname><given-names>KM</given-names></name><name><surname>Flavelle</surname><given-names>S</given-names></name><name><surname>Bureau</surname><given-names>A</given-names></name><name><surname>Glass</surname><given-names>HC</given-names></name><name><surname>Fujiwara</surname><given-names>TM</given-names></name><etal/></person-group><year>2005</year><article-title>Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification.</article-title><source>Am J Hum Genet</source><volume>77</volume><fpage>477</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">16080122</pub-id></citation></ref><ref id="pone.0000252-Niu1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>S</given-names></name><name><surname>Renfro</surname><given-names>A</given-names></name><name><surname>Quattrocchi</surname><given-names>CC</given-names></name><name><surname>Sheldon</surname><given-names>M</given-names></name><name><surname>D'Arcangelo</surname><given-names>G</given-names></name></person-group><year>2004</year><article-title>Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway.</article-title><source>Neuron</source><volume>41</volume><fpage>71</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">14715136</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="pone-0000252-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000252.g001</object-id><label>Figure 1</label><caption><p>Pafah1b2 and Pafah1b3 bind VLDLR but not ApoER2. (A) Pafah1b3 binds VLDLR in transfected cells. Pafah1b3-MYC was co-expressed in 293T cells with GFP- (lanes 1&#x02013;3) or HA-tagged VLDLR (lanes 4&#x02013;6). VLDLR was co-precipitated with MYC antibodies directed against Pafah1b3 (lanes 2 and 5), but not with control antibodies (lanes 3 and 6). Conversely, Pafah1b3 was co-precipitated with HA (lane 9) or GFP (lane 10) directed against VLDLR, but not with control antibodies (lanes 11&#x02013;12). Lanes 1 and 4 show VLDLR, and lanes 7&#x02013;8 show Pafah1b3 in the WCL. Blots were probed with the GFP (lanes 1&#x02013;3), HA (lanes 4&#x02013;6) or Myc antibodies (lanes 7&#x02013;12). (B) Pafah1b2 and Pafah1b3 bind VLDLR in a cell-free-system (TNT). <italic>In vitro</italic> translated proteins were radiolabeled with <sup>35</sup>S and analyzed by SDS-PAGE (lanes 1&#x02013;4). Individual Pafah1b subunits were combined with equal amounts of VLDLR and immunoprecipitated with FLAG (lanes 5&#x02013;7) or a negative control antibody (lanes 8). Proteins were detected by autoradiography. Note that VLDLR co-precipitated with Pafah1b &#x003b1; subunits, but not with Lis1. (C) Pafah1b2 and Pafah1b3 do not bind ApoER2 in transfected cells. ApoER2-GFP was co-expressed in 293T cells with the indicated proteins, and co-immunoprecipitated with HA antibodies directed against Dab1 (lane 1). FLAG antibodies directed against the Pafah1b subunits (lanes 2&#x02013;4) or a control antibody (lane 5) did not co-precipitate the receptor. Blots were probed with antibodies against GFP to detect co-precipitated ApoER2 (upper panel) or total ApoER2 expression in the corresponding WCLs (middle panel). FLAG or HA antibodies were used to detect Pafah1b subunits (lower left panel) or Dab1 (lower right panel) in the corresponding WCLs. ApoER2 co-precipitated exclusively with Dab1. (D) Pafah1b2 and Pafah1b3 do not bind ApoER2 in a cell-free-system (TNT). <italic>In vitro</italic> translated proteins were radiolabeled with <sup>35</sup>S and analyzed by SDS-PAGE (lanes 1&#x02013;4). Equal amounts of ApoER2 were combined with the indicated proteins and immunoprecipitated with a control antibody (lane 5), or with antibodies against Dab1 (lane 6), Pafah1b2 (lane 7) or Pafah1b3 (lane 8). Proteins were detected by autoradiography. ApoER2 again co-precipitated only with Dab1. IP, immunoprecipitate; WCL, whole cell lysate.</p></caption><graphic xlink:href="pone.0000252.g001"/></fig><fig id="pone-0000252-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000252.g002</object-id><label>Figure 2</label><caption><p>Pafah1b2 and Pafah1b3 interact specifically with the NPxY motif of VLDLR. (A) Diagram of the VLDLR expression constructs used in this study. TM&#x0200a;&#x0003d;&#x0200a;transmembrane region. CT&#x0200a;&#x0003d;&#x0200a;cytoplasmic tail. (B) The NPxY motif is required for VLDLR binding to Pafah1b3. Pafah1b3-MYC was co-expressed in 293T cells with the indicated GFP-tagged VLDLR constructs. Proteins were immunoprecipitated with Myc antibodies and the blot was probed with GFP antibodies to detect VLDLR receptors (upper panel). Only full-length VLDLR and the NPxY-containingVLDLR?855 co-precipitated with Pafah1b3. WCLs were probed with GFP (middle panels) or Myc (lower panels) antibodies to ensure that similar amounts of VLDLR or Pafah1b3 proteins were present in each sample. (C) The NPxY motif is required for VLDLR binding to Pafah1b2. FLAG-Pafah1b2 was co-expressed in 293T cells with GFP-tagged VLDLR constructs and immunoprecipitated with FLAG antibodies. Blots were probed with GFP antibodies to detect VLDLR proteins in the IP (upper panel) or WCLs (middle panel), or FLAG antibodies to detect Pafah1b2 in the WCLs (lower panel). Only full-length VLDLR and VLDLR?855 co-precipitated with Pafah1b2. IP, immunoprecipitate; WCL, whole cell lysate.</p></caption><graphic xlink:href="pone.0000252.g002"/></fig><fig id="pone-0000252-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000252.g003</object-id><label>Figure 3</label><caption><p>Substitution of Arg<sup>774</sup> with a Leu in ApoER2 rescues binding to Pafah1b &#x003b1; subunits. (A) Amino acid sequence of VLDLR and ApoER2 near the NPxY motif in the cytoplasmic tail of each receptor. Unique amino acids R774 in ApoER2 and L838 in VLDLR are underlined. (B) A Leu residue following the NPxY motif is required for Pafah1b &#x003b1; subunit binding to lipoprotein receptors. FLAG-tagged intact ApoER2(WT) or a mutant receptor in which Arg<sup>774</sup> was substituted by a Leu ApoER2(R774L) were co-expressed in COS7 cells with GFP-tagged Pafah1b &#x003b1; subunits. Proteins were immunoprecipitated with FLAG antibodies (upper panel) and immunoblotted with antibodies against GFP to detect co-precipitated &#x003b1; subunits. FLAG (middle panel) or GFP (lower panel) antibodies were used to detect ApoER2 receptors or the Pafah1b &#x003b1; subunits in the WCL. Pafah1b2 and Pafah1b2 co-precipitated with ApoER2(R774L), but not with intact ApoER2(WT). IP, immunoprecipitate; WCL, whole cell lysate.</p></caption><graphic xlink:href="pone.0000252.g003"/></fig><fig id="pone-0000252-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000252.g004</object-id><label>Figure 4</label><caption><p>Pafah1b &#x003b1; subunits compete with each other and with Dab1 for binding to VLDLR. (A) Pafah1b &#x003b1; subunits compete for VLDLR binding. Proteins were expressed <italic>in vitro</italic> using a cell-free-system (TNT) and radiolabeled with <sup>35</sup>S (lanes 1&#x02013;3). Equal amounts (50 &#x003bc;l) of VLDLR and Pafah1b3 were incubated with increasing amounts of Pafah1b2, as indicated. Proteins were immunoprecipitated with polyclonal antibodies against VLDLR (lanes 5&#x02013;9) or a control antibody (lane 4) and detected by autoradiography. The plot represents the mean ratio of co-precipitated Pafah1b3 and Pafah1b2 normalized to the amount of precipitated VLDLR in each sample. Increasing amounts of Pafah1b2 reduced the amount of co-precipitated Pafah1b3. (B) Proteins were expressed <italic>in vitro</italic> (TNT) and radiolabeled with <sup>35</sup>S (lanes 1&#x02013;3). Equal amounts (50 &#x003bc;l) of VLDLR and Dab1 were incubated with increasing amounts of Pafah1b3, as indicated. Proteins were immunoprecipitated with polyclonal antibodies against VLDLR (lanes 5&#x02013;9) or a control antibody (lane 4) and detected by autoradiography. The plot represents the mean ratio of co-precipitated Pafah1b3 and Dab1 normalized to the amount of precipitated VLDLR in each sample. Increasing amounts of Pafah1b3 reduced the amount of co-precipitated Dab1. Bars represent the standard error of the mean from triplicate experiments. IP, immunoprecipitate.</p></caption><graphic xlink:href="pone.0000252.g004"/></fig><fig id="pone-0000252-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000252.g005</object-id><label>Figure 5</label><caption><p><italic>reeler</italic>-like disruption of cortical layers in <italic>Pafah1b1 <sup>&#x0002b;/&#x02212;</sup></italic> mice lacking ApoER2 but not VLDLR. Sagittal sections of the neocortex were obtained from adult mice of the indicated genotype. Adjacent sections were stained with cresyl violet (CV) (a-f) or subjected to immunohistochemistry with antibodies against calbindin to label cells in layers II&#x02013;III (g-l), or Foxp2 to label cells in layer VI (s-x). Histograms represent the radial distribution of cells positive for calbindin (m-r) or Foxp2 (y-dd) from the bottom of the cortical plate (set as 0) to the pial surface (set as 100). <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>Vldlr <sup>&#x02212;/&#x02212;</sup></italic> single or double mutants presented no obvious cortical layering defects. <italic>Apoer2 <sup>&#x02212;/&#x02212;</sup></italic> single mutants exhibited some laminar dispersion of upper layer neurons. In contrast, <italic>Pafah1b1 <sup>&#x0002b;/&#x02212;</sup>;Apoer2 <sup>&#x02212;/&#x02212;</sup></italic> double mutants displayed a marked inversions of upper and lower layers (<italic>reeler</italic>-like phenotype) comparable to that seen in <italic>Apoer2 <sup>&#x02212;/&#x02212;</sup>;Vldlr <sup>&#x02212;/&#x02212;</sup></italic> mice. Scale bars&#x0200a;&#x0003d;&#x0200a;500 &#x000b5;m.</p></caption><graphic xlink:href="pone.0000252.g005"/></fig><fig id="pone-0000252-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000252.g006</object-id><label>Figure 6</label><caption><p><italic>reeler</italic>-like disruption of hippocampal layers in <italic>Pafah1b1 <sup>&#x0002b;/&#x02212;</sup></italic>;<italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> double mutants. Comparable sagittal sections of the hippocampus obtained from adult mice of the indicated genotype were stained with cresyl violet. The hippocampus proper (HP) and the dentate gyrus (DG) of <italic>Apoer2<sup>&#x0002b;/&#x02212;</sup></italic> mice are normal, whereas a splitting of the pyramidal layers is evident in <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic> and in <italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> mice. Severe dyslamination of cellular layers is seen in double <italic>Pafah1b1<sup>&#x0002b;/&#x02212;</sup></italic>;<italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> (<italic>reeler</italic>-like). Scale bar&#x0200a;&#x0003d;&#x0200a;500 &#x000b5;m.</p></caption><graphic xlink:href="pone.0000252.g006"/></fig><fig id="pone-0000252-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000252.g007</object-id><label>Figure 7</label><caption><p>Reelin induces Dab1 and Akt phosphorylation in <italic>Pafah1b1 <sup>&#x0002b;/&#x02212;</sup></italic>;<italic>Apoer2<sup>&#x02212;/&#x02212;</sup></italic> double mutant neurons. Cortical neurons were cultured from mutant mice of the indicated genotype, and incubated with either control or Reelin-containing medium for 20 min. Lysates were analyzed by Western blot using the 4G10 antibody to detect Dab1 phosphorylation on tyrosine residues and a phospho-Akt antibody to detect Akt phosphorylation on serine 473. Blots were reprobed with antibodies against total Dab1 and Akt to ensure that similar amount of proteins were present in each sample, and with antibodies against VLDLR and ApoER2 to confirm the genotype of the mutants.</p></caption><graphic xlink:href="pone.0000252.g007"/></fig><fig id="pone-0000252-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000252.g008</object-id><label>Figure 8</label><caption><p>Integrated model of Reelin and Lis1 signaling. Reelin binds to VLDLR and ApoER2 and causes src-family kinase (SFK) activation and Dab1 phosphorylation. Dab1 binds to the NPxY motif of both, VLDLR and ApoER2. Upon Reelin stimulation, phosphoDab1 (P-Dab1) interacts with Lis1 and with other signal transduction molecules (grey circles). Lis1 also binds the catalytic subunits of the Pafah1b complex (&#x003b1;1 and &#x003b1;2) as well as components of the cytoplasmic dynein complex (yellow square). &#x003b1;1 and &#x003b1;2 also bind VLDLR at the NPxY<underline>L</underline> motif and compete with Dab1 for receptor occupancy. These subunits do not recognize the NPxY<underline>R</underline> motif of ApoER2. A unique domain of ApoER2 enables unique interactions with synaptic and trafficking proteins (white octagons). The binding of catalytic Pafah1b subunits to VLDLR may displace P-Dab1 and promote its interaction with Lis1. Signaling molecules downstream of Lis1 and Dab1 affect cytoskeleton dynamics by acting on microtubules (thick lines) or actin filaments (thin lines), thereby controlling neuronal migration and layer formation.</p></caption><graphic xlink:href="pone.0000252.g008"/></fig></sec><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>Supported by a grant from the National Institute of Disorders and Stroke/NIH R01 NS042616 (G.D.), NIH grants HL20948, HL63762, NS43408, the Perot Family Foundation and the Humboldt Foundation (J.H.) and by the Mental Retardation and Developmental Disabilities Research Center (MRDDRC) at Baylor College of Medicine.</p></fn></fn-group></back></article> 